Crossmark

Deeper insights into long-term survival heterogeneity of pancreatic ductal adenocarcinoma (PDAC) patients using integrative individual- and group-level transcriptome network analyses

Crossref DOI link: https://doi.org/10.1038/s41598-022-14592-1

Published Online: 2022-06-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bhardwaj, Archana

Josse, Claire

Van Daele, Daniel

Poulet, Christophe

Chavez, Marcela

Struman, Ingrid

Van Steen, Kristel
Funding

Funding for this research was provided by:

Télévie 2015 “PDAC-xome: Exome sequencing in PDAC

Télévie 2016 “Drivers and markers in pancreatic cancer

FRS-FNRS – CDR 2017 “SysMedPC”
License Information

Text and Data Mining valid from 2022-06-30

Version of Record valid from 2022-06-30
More Information

Article History

Received: 9 July 2021

Accepted: 9 June 2022

First Online: 30 June 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below